alexa Abstract | Antihypertyensive Drugs used during Pregnancy: an Evaluation

Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article Open Access


BACKGROUND & OBJECTIVES: Hypertensive disorders during pregnancy are a leading cause of maternal mortality occurring in 5-10 percent of pregnancies. While the goal of treatment is to reduce maternal risk, the agents selected must be efficacious and safe for the foetus. Thus, the present study was carried out with objectives to assess the prevalence of hypertensive disorders during pregnancy, the prescribing pattern to treat these conditions and to monitor adverse drug reactions. METHODOLGY: A six months prospective study was carried out at a tertiary care hospital, after obtaining Ethical clearance. Data was collected from the antenatal cards and case sheets of all pregnant women diagnosed with elevated BP and admitted to the wards. Classification of hypertensive disorders of the patients were performed according to the criteria by Davey and Mac Gillivray, American College of Obstetrics & Gynecology (ACOG) and endorsed by the International Society for the Study of Hypertension in Pregnancy (ISSHP). RESULTS & CONCLUSION: 152 patients met inclusion criteria. Prevalence of hypertensive disorders during pregnancy was found to be 12.2%. Based on the classification , 65% of patients had Gestational Hypertension, 26% had Pre-eclampsia/Eclampsia and 9% had Chronic Hypertension. The most commonly prescribed medicines to treat the hypertensive disorders during pregnancy were Nifedipine, Methyldopa, MgSO4, Atenolol, Furosemide and their combinations. Nifedipine was widely used in patients with Gestational Hypertension (14.1%) and Pre-eclampsia/Eclampsia (22.5%). For Chronic Hypertension, a combination of Nifedipine and Methyldopa (38.5%) were prescribed. The treatment given for the management of hypertensive disorders during pregnancy was found to be at par with the guidelines.

To read the full article Peer-reviewed Article PDF image

Author(s): Leena Alfred, Shobha Rani R. H., Surjith K. Sharma, Jai Prakash S. Vastrad, *Mahvash Iram


Antihypertensive drugs, eclampsia, gestational hypertension, pre-eclampsia, pregnancy, Physiological Changes during Pregnancy

Recommended Journals

Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version